Ethyl pyruvate ameliorates acute alcohol-induced liver injury and inflammation in mice

被引:82
作者
Yang, RK
Han, XN
Delude, RL
Fink, MP
机构
[1] Univ Pittsburgh, Sch Med, Dept Crit Care Med, Pittsburgh, PA 15261 USA
[2] Univ Pittsburgh, Sch Med, Dept Pathol, Pittsburgh, PA 15261 USA
[3] Univ Pittsburgh, Sch Med, Dept Surg, Pittsburgh, PA 15261 USA
来源
JOURNAL OF LABORATORY AND CLINICAL MEDICINE | 2003年 / 142卷 / 05期
基金
美国国家卫生研究院;
关键词
D O I
10.1016/S0022-2143(03)00138-0
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Ethyl pyruvate dissolved in a calcium-containing balanced salt solution-Ringer's ethyl pyruvate solution (REPS)-ameliorates ileal mucosal hyperpermeability and decreases the expression of several proinflammatory genes when it is used instead of Ringer's lactate solution (RLS) to resuscitate mice from hemorrhagic shock. Herein, we sought to determine whether delayed treatment with REPS would be beneficial in a murine model of acute alcoholic liver injury associated with binge drinking. Mice were gavaged with 3 doses of ethanol (5 g/kg each dose) over a 12-hour period and then randomized to treatment with 3 intraperitoneal doses of REPS or RLS over 12 hours. Compared with sham-treated controls not subjected to alcohol intoxication, RLS-treated mice demonstrated histologic evidence of fatty change and piecemeal necrosis of hepatocytes in the liver, as well as a significant increase in the plasma concentration of alanine aminotransferase. Biochemical changes induced by alcohol administration included increased hepatic lipid peroxidation, nuclear factor-kappaB activation, and tumor necrosis factor-a. messenger RNA expression. All of these alcohol-induced effects were ameliorated by treatment with REPS instead of RLS. These data support the view that treatment with REPS ameliorates the hepatic inflammatory response and decreases hepatocellular injury in mice subjected to acute alcohol intoxication.
引用
收藏
页码:322 / 331
页数:10
相关论文
共 68 条
  • [51] SPITZER TS, 2003, JAMA-J AM MED ASSOC, V289, P70
  • [52] Lipopolysaccharides in liver injury: molecular mechanisms of Kupffer cell activation
    Su, GL
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY, 2002, 283 (02): : G256 - G265
  • [53] New insights into the molecular mechanisms of alcoholic hepatitis:: A potential role for NF-κB activation?
    Szabo, G
    [J]. JOURNAL OF LABORATORY AND CLINICAL MEDICINE, 2000, 135 (05): : 367 - 369
  • [54] Bacterial translocation and peptidoglycan translocation by acute ethanol administration
    Tabata, T
    Tani, T
    Endo, Y
    Hanasawa, K
    [J]. JOURNAL OF GASTROENTEROLOGY, 2002, 37 (09) : 726 - 731
  • [55] Effect of acute ethanol administration on the intestinal absorption of endotoxin in rats
    Tamai, H
    Kato, S
    Horie, Y
    Ohki, E
    Yokoyama, H
    Ishii, H
    [J]. ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2000, 24 (03) : 390 - 394
  • [56] Resuscitation from hemorrhagic shock with Ringer's ethyl pyruvate solution improves survival and ameliorates intestinal mucosal hyperpermeability in rats
    Tawadrous, ZS
    Delude, RL
    Fink, MP
    [J]. SHOCK, 2002, 17 (06): : 473 - 477
  • [57] Mechanisms of Hepatic Toxicity II. Alcoholic liver injury involves activation of Kupffer cells by endotoxin
    Thurman, RG
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY, 1998, 275 (04): : G605 - G611
  • [58] Delivery of IκB superrepressor gene with adenovirus reduces early alcohol-induced liver injury in rats
    Uesugi, T
    Froh, M
    Arteel, GE
    Bradford, BU
    Gäbele, E
    Wheeler, MD
    Thurman, RG
    [J]. HEPATOLOGY, 2001, 34 (06) : 1149 - 1157
  • [59] Ethyl pyruvate prevents lethality in mice with established lethal sepsis and systemic inflammation
    Ulloa, L
    Ochani, M
    Yang, H
    Tanovic, M
    Halperin, D
    Yang, R
    Czura, CJ
    Fink, MP
    Tracey, KJ
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (19) : 12351 - 12356
  • [60] Effect of ethanol on B cell expression of major histocompatibility class II proteins in immunized mice
    Weiss, PA
    Collier, SD
    Pruett, SB
    [J]. IMMUNOPHARMACOLOGY, 1998, 39 (01): : 61 - 72